| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Chief Legal & Compliance, Secretary | Restricted Stock Unit | 200K | $992K | $4.96 | Jun 21, 2024 | Direct |
| Gritstone bio, Inc. | EVP and General Counsel | Common Stock | 58.7K | $112K | $1.90 | Jan 31, 2022 | Direct |
| Lyell Immunopharma, Inc. | Chief Legal Officer | Option (right to buy) | 245K | Feb 24, 2023 | Direct | ||
| Gritstone bio, Inc. | EVP and General Counsel | Stock Option (Right to Buy) | 115K | Jan 31, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ZVRA | ZEVRA THERAPEUTICS, INC. | Jun 21, 2024 | 1 | $0 | 4 | Jun 25, 2024 | Chief Legal & Compliance, Secretary |
| ZVRA | ZEVRA THERAPEUTICS, INC. | Jun 21, 2024 | 0 | $0 | 3 | Jun 25, 2024 | Chief Legal & Compliance, Secretary |
| LYEL | Lyell Immunopharma, Inc. | Feb 24, 2023 | 1 | $0 | 4 | Feb 28, 2023 | Chief Legal Officer |
| LYEL | Lyell Immunopharma, Inc. | Oct 10, 2022 | 1 | $0 | 4 | Oct 12, 2022 | Chief Legal Officer |
| LYEL | Lyell Immunopharma, Inc. | Sep 28, 2022 | 0 | $0 | 3 | Oct 3, 2022 | Chief Legal Officer |
| GRTS | Gritstone bio, Inc. | Jan 31, 2022 | 2 | $0 | 4 | Apr 20, 2022 | EVP and General Counsel |
| GRTS | Gritstone bio, Inc. | Jan 7, 2021 | 1 | $0 | 4 | Nov 19, 2021 | EVP and General Counsel |